Roughly 30,000 Americans are diagnosed with multiple myeloma each year—a rare but serious cancer of the plasma cells. Historically treated with chemotherapy, patients often faced recurring disease and…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Richard Gallagher, MD, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in treating…
Richard Gallagher, MD, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in treating…
Richard Gallagher, MD, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in treating…
Dr. Richard Gallagher, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in treating…
Richard Gallagher, MD, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in treating…
Richard Gallagher, MD, Professor of Clinical Psychiatry at New York Medical College and also a faculty member of the Columbia University Psychoanalytic Center, discusses best practices in diagnosing…
NEW YORK (Reuters Health) – In order to minimize the risk of potential harms, erythropoiesis-stimulating agents (ESAs) in patients undergoing myelosuppressive chemotherapy should be administered at the lowest…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
NEW YORK (Reuters Health) – Results of a clinical trial of the new, long-acting neuraminidase inhibitor laninamivir octanoate show that it is not inferior to oseltamivir in treating…
